Holen Sie sich die Stockscreener-App
689.93
1.65%
-11.55
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$701.48
Offen:
$695.92
24-Stunden-Volumen:
469.22K
Relative Volume:
1.03
Marktkapitalisierung:
$55.20B
Einnahmen:
$4.17B
Nettoeinkommen (Verlust:
$1.03B
KGV:
54.69
EPS:
12.6148
Netto-Cashflow:
$940.22M
1W Leistung:
-2.61%
1M Leistung:
+8.32%
6M Leistung:
+35.43%
1J Leistung:
+62.85%
1-Tages-Spanne:
$688.66
$699.66
1-Wochen-Bereich:
$688.66
$719.25
52-Wochen-Spanne:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Why retail investors favor IDEXX Laboratories Inc. stockJuly 2025 News Drivers & Daily Technical Forecast Reports - newser.com
Does IDEXX Laboratories Inc. fit your quant trading modelPortfolio Return Report & Weekly High Momentum Picks - newser.com
Is IDEXX Laboratories Inc. stock supported by strong cash flowsCEO Change & Consistent Profit Trade Alerts - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervalued2025 Growth vs Value & Technical Pattern Based Buy Signals - newser.com
Will IDEXX Laboratories Inc. stock recover after recent dropJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is IDEXX Laboratories Inc. (IX1) stock prepared for digital transitionWeekly Trend Summary & Daily Growth Stock Tips - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Ideas & Community Trade Idea Sharing - newser.com
IDEXX Laboratories Amends Credit Agreement for Flexibility - TipRanks
Building trade automation scripts for IDEXX Laboratories Inc.2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Trend analysis for IDEXX Laboratories Inc. this weekWeekly Gains Summary & Verified Entry Point Signals - newser.com
Idexx Laboratories Shares Reach New Highs Amid Insider Selling Activity - AD HOC NEWS
Insider Move: Nimrata Hunt Exercises Options, Realizing $4.10M At IDEXX Laboratories - Benzinga
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing - MarketScreener
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.63 Million in Common Stock - 富途牛牛
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $775 - 富途牛牛
Here’s Why IDEXX Laboratories (IDXX) Surged in Q3 - Insider Monkey
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700 - MarketScreener
What machine learning models say about IDEXX Laboratories Inc.2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
What analyst consensus implies for IDEXX Laboratories Inc. (IX1) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
1.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):